The FDA is informing the public about the results of a meta-analysis that compared patients who received Chantix (varenicline; Pfizer) to patients who received placebo.
The Food and Drug Administration (FDA) has announced that the labeling for varenicline (Chantix; Pfizer) has been updated to include information on changes to alcohol tolerance and risk of seizures associated with use of the drug.